睿智医药 (300149) 财务报表

截止日期2022-09-302022-06-302022-03-312021-12-312021-09-30
营业总收入(万元)103223.7468689.6538630.19169067.79126148.35
营业收入(万元)103223.7468689.6538630.19169067.79126148.35
营业总成本(万元)99487.6471329.6736898.49169926.01126107.85
营业成本(万元)66031.0244995.1123343.19115490.8486966.58
净利润(万元)102322.7995653.75941.67-40209.681469.65
归属于母公司的净利润(万元)102339.1895658.47947.10-40224.511483.32
营业利润(万元)139855.73132400.181144.93-35540.291314.72
利润总额(万元)139810.13132376.171145.23-36102.991257.65
少数股东损益(万元)-16.39-4.72-5.4314.83-13.66
基本每股收益(元)2.05(元)1.92(元)0.02(元)-0.81(元)0.03(元)
稀释每股收益(元)2.05(元)1.92(元)0.02(元)-0.81(元)0.03(元)
非经常性损益(万元)99581.8999157.59128.572005.891192.47
扣除非经常性损益后净利润(万元)2757.29-3499.12818.53-42230.39290.84
总资产(万元)470444.72482719.04421561.41421759.15481983.19
总负债(万元)166799.02187482.59222304.21222851.46240861.04
归属于母公司股东权益合计(万元)301198.85292777.94196799.39196444.46238687.41
股东权益合计(万元)303645.69295236.45199257.20198907.69241122.15
实收资本(股本)(万元)49977.6949977.6949977.6949977.6949977.69
资本公积(万元)--122918.72122918.72122918.72122932.36
未分配利润(万元)123517.86116837.1522125.7821178.6862886.51
经营活动产生的现金流量净额(万元)-6438.074273.323494.4837821.9926213.52
经营活动现金流入小计(万元)108231.5069406.4034214.94187245.59147858.07
经营活动现金流出小计(万元)114669.5665133.0930720.46149423.60121644.55
投资活动产生的现金流量净额(万元)129555.47136293.21-3832.97-21088.72-24915.66
投资活动现金流入小计(万元)163066.09161860.723675.7246884.5231598.28
投资活动现金流出小计(万元)33510.6225567.517508.6967973.2456513.94
筹资活动产生的现金流量净额(万元)-70549.24-67656.74-9563.32-25936.064728.83
筹资活动现金流入小计(万元)22600.0011600.002000.0039476.5343355.83
筹资活动现金流出小计(万元)93149.2479256.7411563.3265412.5938627.00
期末现金及现金等价物余额(万元)70362.9187572.645358.2715299.3030533.28
最后修改日期2022-10-262022-08-302022-04-302022-04-302021-11-13